Developer docs
API playgroundTry for free, no card

Search company profiles

Gummy USA

Full company profile

uuid00q451g

Namestring
Gummy USA
Legal namestring
Gummy USA
Websiteurl
gummyusa.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Gummy USA is a Sarasota, Florida-based B2B contract manufacturer of custom gummy nutraceutical supplements, serving supplement, health, and beauty brands that want to launch or convert products into gummy form. The company was acquired by Healthy Extracts Inc. (OTCQB:HYEX) in July 2025 and now operates as a wholly owned subsidiary within a vertically integrated platform spanning ingredient acquisition, product development, patenting, manufacturing, and multi-channel distribution. Services include formulation consultation, flavor testing, pilot runs at low minimum order quantities (5,000 bottles), full-scale production, and packaging with compliance documentation for labels, claims, and FDA/GMP requirements. Target customers include established supplement brands, wellness companies, beauty brands (e.g., Imaraï's Beauty co-founded by Sommer Ray), and women's health nutraceutical companies.

The company's core product categories—multivitamin, immune support (Vitamin C, Zinc, Elderberry), energy and fitness (BCAAs, pre-workout, focus), and kids' gummies—are manufactured in an FDA-registered, GMP-certified U.S. facility. Differentiating technical features include dedicated drying tunnels for each production run (preventing cross-contamination, flavor bleed, and ingredient mix-ups), patent-pending equipment innovations that reduce production time, explicit no-hemp/no-CBD processing for cleaner compliance, and a 60-day time-to-market capability versus an industry-standard 90–120 days. Capsule and powder conversion services extend the platform to brands seeking format migration without in-house gummy expertise.

Gummy USA operates on a quote-based, per-unit B2B manufacturing fee model with pay-as-you-go billing. Distribution flows through brand partner retail relationships—the Imaraï's Beauty partnership alone reaches over 4,800 store locations with end-cap placements at a leading national retailer. Named enterprise contracts disclosed include nearly 4 million gummies across 5 SKUs for Imaraï's Beauty (April 2026) and a 6 million gummy follow-on order for women's health supplements (October 2025). At the parent level, Healthy Extracts reported Q1 2026 net revenue of $1.6M (+73% YoY), gross margins of 61.4% (up from 45.6%), positive EBITDA of $40,500, and a 2026 net revenue target of over $20M.

Short descriptiontext

Gummy USA is a Sarasota, Florida-based B2B contract manufacturer of custom gummy supplements for supplement, health, and beauty brands. Wholly owned subsidiary of Healthy Extracts Inc., it offers FDA-registered, GMP-certified manufacturing with 60-day launch capabilities.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersSarasota, United States
HQ citystring
Sarasota
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
custom gummy manufacturing, nutraceutical contract manufacturing, private label gummies, supplement formulation services, gummy production packaging
Industry1 code
1Sugar Confectionery (Gummies, Hard Candy, Chews)
CodeCRADABABPrimaryYes
NAICS code1 code
  • Nonchocolate Confectionery Manufacturing311340
SIC code1 code
  • Sugar & Confectionery Products2060
Product category
Nutraceutical Contract Manufacturing
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1B2B Gummy Manufacturing
TypeOne Time License
Description

Contract manufacturing of custom gummy supplements for supplement brands. Services include formulation, flavor testing, pilot runs, and full-scale production and packaging. Revenue generated through per-unit manufacturing fees based on production orders.

gummyusa.com
2Manufacturing Partnerships
TypeOne Time License
Description

Strategic manufacturing partnerships with brands like Imaraïs Beauty for production of specific product lines. Initial orders of nearly 4 million gummies across multiple SKUs demonstrate large-scale production revenue streams.

stocktitan.net
3Ingredient to Distribution Platform
TypeOne Time License
Description

Vertically integrated platform spanning ingredient acquisition, product development, patenting, manufacturing, and multi-channel distribution generating revenue across the value chain.

arcstonefinancialpulse.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details2 tiers
1Low Minimum Order - Start at 5,000 bottles
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Entry-level tier for brands launching gummy products with low minimum order quantity of 5,000 bottles. Includes formulation, flavor testing, pilot run, and full production support.

gummyusa.com
2Enterprise Manufacturing Partnerships
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Large-scale production orders such as the 4 million gummy order for Imaraïs Beauty and 6 million gummy follow-on orders for women's health supplements. Pricing based on volume with multi-SKU capabilities.

gummyusa.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Gummy USA manufactures custom gummy supplements on a contract basis for supplement, wellness, and beauty brands. Services span end-to-end production including custom formulation, flavor development and testing, low-MOQ pilot runs, and full-scale production and packaging with FDA/GMP compliance documentation. The company also converts existing capsule and powder formulations into gummy formats and supports categories including multivitamins, immune support, energy/fitness, and kids' gummies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 60-day launch time vs industry average of 90-120 days
+3 more records
Product overview1 text field

Gummy USA operates as a premium gummy supplement manufacturing platform offering vertically integrated services from formulation to production and packaging. The core product portfolio includes Multivitamin Gummies, Immune Support Gummies, Energy & Fitness Gummies, and Kids' Gummies. Supporting services include capsule and powder conversion, formulation and flavor testing, pilot run production, and full-scale manufacturing and packaging. The company differentiates through 60-day market launch capability, dedicated drying tunnels to prevent cross-contamination, and U.S.-based FDA-registered, GMP-certified production with no hemp or CBD products.

Product and service5 records
1Custom Gummy Supplement Manufacturing
CategoryContract Manufacturing Services
Description

Turnkey B2B custom gummy manufacturing service for supplement and wellness brands, covering formulation consultation, flavor testing, pilot runs, full production, and packaging with FDA/GMP compliance documentation. Targets brands seeking U.S.-based production with 5,000-bottle minimums and 60-day launches.

2Capsule and Powder to Gummy Conversion
CategoryConversion Services
Description

Specialty conversion service that transforms brands' existing capsule and powder supplement products into gummy format using Gummy USA's formulation and flavor expertise, enabling product differentiation and improved consumer compliance.

3Formulation and Flavor Development
CategoryProduct Development Services
Description

Expert formulation matching or creation plus iterative flavor testing with samples, leveraging decades of formulation science experience to craft gummies that meet brand specifications for taste, texture, and nutritional profile.

4Pilot Run / Low-MOQ Production
CategoryManufacturing Services
Description

Small-batch pilot production service enabling brands to validate formulations, packaging, and market response before committing to full-scale manufacturing runs.

5Full-Scale Production and Packaging
CategoryManufacturing Services
Description

Full-volume manufacturing and packaging service producing finished, retail-ready gummy products at scale, with included compliance support for labels, claims, and FDA/GMP documentation.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-16
Description

Gummy USA has entered a U.S. manufacturing partnership with Imaraïs Beauty, a plant-based ingestible beauty and wellness brand co-founded by Sommer Ray and Aaron Hefter. The partnership launched with an initial order of nearly four million gummies across five SKUs, planned for distribution to over 4,800 store locations nationwide with prominent isle end-cap placements at a leading national retailer. Both companies have characterized this as the beginning of a transformative partnership to accelerate manufacturing output and expand presence in the $725 billion global health and beauty market.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-07-01
Description

Healthy Extracts Inc. completed a merger with Gummy USA (July 2025), making Gummy USA a wholly owned subsidiary. Healthy Extracts operates a vertically integrated platform spanning ingredient acquisition, product development, patenting, manufacturing, and multi-channel distribution. The merger added FDA-registered, GMP-certified manufacturing capacity scalable to over $20M in annual revenues.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US custom gummy supplement contract manufacturer. Closely comparable to Gummy USA on private-label/custom gummy production, formulation expertise, and serving nutraceutical brand customers.

TypeBroad incumbent
Description

Global pharmaceutical and nutraceutical manufacturer with capsule, softgel, and emerging gummy capabilities. Comparable as a broad incumbent in supplement contract manufacturing, though gummy is a smaller part of its portfolio relative to its core capsule business.

TypeDirect peer
Description

Large US contract manufacturer of nutritional supplements in multiple formats including gummies. Comparable to Gummy USA in serving brand customers with custom manufacturing, GMP-certified production, and full-service formulation-to-packaging.

TypeDirect peer
Description

US-based contract manufacturer of dietary supplements including gummy vitamins and soft chews. Directly comparable as a B2B custom supplement manufacturer serving brand customers with formulation, flavoring, and full production capabilities.

TypeDirect peer
Description

US-based contract supplement manufacturer offering custom gummy manufacturing for brands. Directly comparable on custom formulation, pilot runs, low minimums, and full-scale gummy production.

TypeDirect peer
Description

Canadian-based gummy supplement manufacturer offering private-label and custom gummy production. Directly comparable on product category (gummy nutraceuticals) and contract manufacturing model.

TypeRegional player
Description

German-based contract manufacturer of vitamin and supplement premixes including gummy formulations. Comparable as a regional custom manufacturer of supplement delivery formats serving brand customers, though primarily serving European markets.

TypeBroad incumbent
Description

Latin American pharmaceutical and nutraceutical contract manufacturer with gummy and softgel capabilities. Comparable as a larger incumbent in the contract supplement manufacturing space with broader geographic reach and product format portfolio.

TypeDirect peer
Description

US contract manufacturer specializing in supplement gummies and chews. Comparable on the contract manufacturing business model, FDA/GMP compliance, and serving health & wellness brand customers.

TypeBroad incumbent
Description

Global large-scale CDMO offering soft chew and gummy manufacturing for pharmaceutical and consumer health customers. Comparable as a broader incumbent with overlapping capabilities in gummy delivery formats and contract manufacturing for health brands.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Gummy USA

Nutraceutical Contract Manufacturinggummyusa.com

Gummy USA is a Sarasota, Florida-based B2B contract manufacturer of custom gummy supplements for supplement, health, and beauty brands. Wholly owned subsidiary of Healthy Extracts Inc., it offers FDA-registered, GMP-certified manufacturing with 60-day launch capabilities.

What Gummy USA does

Gummy USA is a Sarasota, Florida-based B2B contract manufacturer of custom gummy nutraceutical supplements, serving supplement, health, and beauty brands that want to launch or convert products into gummy form. The company was acquired by Healthy Extracts Inc. (OTCQB:HYEX) in July 2025 and now operates as a wholly owned subsidiary within a vertically integrated platform spanning ingredient acquisition, product development, patenting, manufacturing, and multi-channel distribution. Services include formulation consultation, flavor testing, pilot runs at low minimum order quantities (5,000 bottles), full-scale production, and packaging with compliance documentation for labels, claims, and FDA/GMP requirements. Target customers include established supplement brands, wellness companies, beauty brands (e.g., Imaraï's Beauty co-founded by Sommer Ray), and women's health nutraceutical companies.

The company's core product categories—multivitamin, immune support (Vitamin C, Zinc, Elderberry), energy and fitness (BCAAs, pre-workout, focus), and kids' gummies—are manufactured in an FDA-registered, GMP-certified U.S. facility. Differentiating technical features include dedicated drying tunnels for each production run (preventing cross-contamination, flavor bleed, and ingredient mix-ups), patent-pending equipment innovations that reduce production time, explicit no-hemp/no-CBD processing for cleaner compliance, and a 60-day time-to-market capability versus an industry-standard 90–120 days. Capsule and powder conversion services extend the platform to brands seeking format migration without in-house gummy expertise.

Gummy USA operates on a quote-based, per-unit B2B manufacturing fee model with pay-as-you-go billing. Distribution flows through brand partner retail relationships—the Imaraï's Beauty partnership alone reaches over 4,800 store locations with end-cap placements at a leading national retailer. Named enterprise contracts disclosed include nearly 4 million gummies across 5 SKUs for Imaraï's Beauty (April 2026) and a 6 million gummy follow-on order for women's health supplements (October 2025). At the parent level, Healthy Extracts reported Q1 2026 net revenue of $1.6M (+73% YoY), gross margins of 61.4% (up from 45.6%), positive EBITDA of $40,500, and a 2026 net revenue target of over $20M.

Gummy USA firmographics

Firmographics
Name
Gummy USA
Legal name
Gummy USA
Website
https://gummyusa.com
Company type
Private
Operating status
Operating
Short description
Gummy USA is a Sarasota, Florida-based B2B contract manufacturer of custom gummy supplements for supplement, health, and beauty brands. Wholly owned subsidiary of Healthy Extracts Inc., it offers FDA-registered, GMP-certified manufacturing with 60-day launch capabilities.
Ownership category
akta.pro rank

Gummy USA industry classification

Industry
Product category
Nutraceutical Contract Manufacturing
NAICS
Nonchocolate Confectionery Manufacturing (311340)
SIC
Sugar & Confectionery Products (2060)
akta.pro primary industry
Sugar Confectionery (Gummies, Hard Candy, Chews) (CRADABAB)

Keywords

  • Custom gummy manufacturing
  • Nutraceutical contract manufacturing
  • Private label gummies
  • Supplement formulation services
  • Gummy production packaging

Where Gummy USA is headquartered

Location

Headquarters

HQ city
Sarasota
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Gummy USA business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. B2B Gummy Manufacturing: Contract manufacturing of custom gummy supplements for supplement brands. Services include formulation, flavor testing, pilot runs, and full-scale production and packaging. Revenue generated through per-unit manufacturing fees based on production orders.
  2. Manufacturing Partnerships: Strategic manufacturing partnerships with brands like Imaraïs Beauty for production of specific product lines. Initial orders of nearly 4 million gummies across multiple SKUs demonstrate large-scale production revenue streams.
  3. Ingredient to Distribution Platform: Vertically integrated platform spanning ingredient acquisition, product development, patenting, manufacturing, and multi-channel distribution generating revenue across the value chain.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goLow Minimum Order - Start at 5,000 bottles
Unit PricingPay-as-you-goEnterprise Manufacturing Partnerships

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Gummy USA product offering

Product offering

Core offering

Gummy USA manufactures custom gummy supplements on a contract basis for supplement, wellness, and beauty brands. Services span end-to-end production including custom formulation, flavor development and testing, low-MOQ pilot runs, and full-scale production and packaging with FDA/GMP compliance documentation. The company also converts existing capsule and powder formulations into gummy formats and supports categories including multivitamins, immune support, energy/fitness, and kids' gummies.

Product overview

Gummy USA operates as a premium gummy supplement manufacturing platform offering vertically integrated services from formulation to production and packaging. The core product portfolio includes Multivitamin Gummies, Immune Support Gummies, Energy & Fitness Gummies, and Kids' Gummies. Supporting services include capsule and powder conversion, formulation and flavor testing, pilot run production, and full-scale manufacturing and packaging. The company differentiates through 60-day market launch capability, dedicated drying tunnels to prevent cross-contamination, and U.S.-based FDA-registered, GMP-certified production with no hemp or CBD products.

Differentiator

Problem solved

Functional benefit

Products and services

  • Custom Gummy Supplement Manufacturing Turnkey B2B custom gummy manufacturing service for supplement and wellness brands, covering formulation consultation, flavor testing, pilot runs, full production, and packaging with FDA/GMP compliance documentation. Targets brands seeking U.S.-based production with 5,000-bottle minimums and 60-day launches.
  • Capsule and Powder to Gummy Conversion Specialty conversion service that transforms brands' existing capsule and powder supplement products into gummy format using Gummy USA's formulation and flavor expertise, enabling product differentiation and improved consumer compliance.
  • Formulation and Flavor Development Expert formulation matching or creation plus iterative flavor testing with samples, leveraging decades of formulation science experience to craft gummies that meet brand specifications for taste, texture, and nutritional profile.
  • Pilot Run / Low-MOQ Production Small-batch pilot production service enabling brands to validate formulations, packaging, and market response before committing to full-scale manufacturing runs.
  • Full-Scale Production and Packaging Full-volume manufacturing and packaging service producing finished, retail-ready gummy products at scale, with included compliance support for labels, claims, and FDA/GMP documentation.

Quantifiable outcome

  • 60-day launch time vs industry average of 90-120 days
  • +3 more outcomes

Companies that use Gummy USA

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Gummy USA technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Gummy USA partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Imaraïs BeautycoreStrategic or Co-development Partner · 16 April 2026Gummy USA has entered a U.S. manufacturing partnership with Imaraïs Beauty, a plant-based ingestible beauty and wellness brand co-founded by Sommer Ray and Aaron Hefter. The partnership launched with an initial order of nearly four million gummies across five SKUs, planned for distribution to over 4,800 store locations nationwide with prominent isle end-cap placements at a leading national retailer. Both companies have characterized this as the beginning of a transformative partnership to accelerate manufacturing output and expand presence in the $725 billion global health and beauty market.
  • Healthy Extracts Inc.coreStrategic or Co-development Partner · 1 July 2025Healthy Extracts Inc. completed a merger with Gummy USA (July 2025), making Gummy USA a wholly owned subsidiary. Healthy Extracts operates a vertically integrated platform spanning ingredient acquisition, product development, patenting, manufacturing, and multi-channel distribution. The merger added FDA-registered, GMP-certified manufacturing capacity scalable to over $20M in annual revenues.

Scale indicators11 records

Recent moves5 records

Expansion highlights5 records

Gummy USA competitors and assessment

Company assessment

Direct peers

  • Vitakem: US custom gummy supplement contract manufacturer. Closely comparable to Gummy USA on private-label/custom gummy production, formulation expertise, and serving nutraceutical brand customers.
  • Best Formulations: Large US contract manufacturer of nutritional supplements in multiple formats including gummies. Comparable to Gummy USA in serving brand customers with custom manufacturing, GMP-certified production, and full-service formulation-to-packaging.
  • Makers Nutrition: US-based contract manufacturer of dietary supplements including gummy vitamins and soft chews. Directly comparable as a B2B custom supplement manufacturer serving brand customers with formulation, flavoring, and full production capabilities.
  • NutraScience Labs: US-based contract supplement manufacturer offering custom gummy manufacturing for brands. Directly comparable on custom formulation, pilot runs, low minimums, and full-scale gummy production.
  • Herbaland: Canadian-based gummy supplement manufacturer offering private-label and custom gummy production. Directly comparable on product category (gummy nutraceuticals) and contract manufacturing model.
  • Arizona Nutritional Supplements (ANS): US contract manufacturer specializing in supplement gummies and chews. Comparable on the contract manufacturing business model, FDA/GMP compliance, and serving health & wellness brand customers.

Broad incumbents

  • Lonza Capsules & Health Ingredients: Global pharmaceutical and nutraceutical manufacturer with capsule, softgel, and emerging gummy capabilities. Comparable as a broad incumbent in supplement contract manufacturing, though gummy is a smaller part of its portfolio relative to its core capsule business.
  • Procaps Group: Latin American pharmaceutical and nutraceutical contract manufacturer with gummy and softgel capabilities. Comparable as a larger incumbent in the contract supplement manufacturing space with broader geographic reach and product format portfolio.
  • Catalent (now part of Novo Holdings): Global large-scale CDMO offering soft chew and gummy manufacturing for pharmaceutical and consumer health customers. Comparable as a broader incumbent with overlapping capabilities in gummy delivery formats and contract manufacturing for health brands.

Regional players

  • SternVitamin: German-based contract manufacturer of vitamin and supplement premixes including gummy formulations. Comparable as a regional custom manufacturer of supplement delivery formats serving brand customers, though primarily serving European markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Gummy USA social profiles

Digital presence

Gummy USA compliance and trust

Trust signal

Compliance2 records

Gummy USA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Gummy USA leadership team

Management profile

Number of profiles

Gummy USA funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Gummy USA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gummy USA

What does Gummy USA do?

Gummy USA manufactures custom gummy supplements on a contract basis for supplement, wellness, and beauty brands. Services span end-to-end production including custom formulation, flavor development and testing, low-MOQ pilot runs, and full-scale production and packaging with FDA/GMP compliance documentation. The company also converts existing capsule and powder formulations into gummy formats and supports categories including multivitamins, immune support, energy/fitness, and kids' gummies.

Is Gummy USA a public or private company?

Gummy USA is a private company. It is classified as corporate owned and is currently operating.

When was Gummy USA founded?

Gummy USA was founded in -1.

Where is Gummy USA based?

Gummy USA is headquartered in Sarasota, United States, in the North America region.

How does Gummy USA make money?

Three revenue lines are on record. B2B Gummy Manufacturing is the primary driver. The others are manufacturing Partnerships and ingredient to Distribution Platform.

Who are Gummy USA's main competitors?

Direct peers on record are Vitakem, Best Formulations, Makers Nutrition, NutraScience Labs, Herbaland and Arizona Nutritional Supplements (ANS). Broad incumbents are Lonza Capsules & Health Ingredients, Procaps Group and Catalent (now part of Novo Holdings). SternVitamin is listed as a regional player.

Does Gummy USA have an API?

No public API is recorded for Gummy USA.

What industry is Gummy USA in?

Gummy USA's product category is Nutraceutical Contract Manufacturing. Its primary akta.pro industry code is CRADABAB, Sugar Confectionery (Gummies, Hard Candy, Chews). Its NAICS code is 311340 and its SIC code is 2060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageHealthy Extracts Q2 2026 Net Revenue Up 113% to Record $2.1 Million, Driving Adj. EBITDA of $290,000 or $0.02 per ShareHealthy Extracts Inc. reported a 113% increase in net revenue to a record $2.1 million for Q2 2026, which is attributed to its merger with Gummy USA and the acquisition of Imaraïs Beauty. The company's adjusted EBITDA rose to $290,000, despite a net loss of $129,000 for the same quarter. The strong performance reflects a positive outlook for continued growth and market expansion in the nutraceutical and health sectors.Stock TitanHealthy Extracts Q2 Earnings: Revenue Up 113% to $2.1MHealthy Extracts Inc. reported a 113% year-over-year increase in Q2 2026 net revenue to $2.1 million, driven by its acquisition of Imaraïs Beauty and merger with Gummy USA. Despite the top-line growth, the company posted a net loss of $129,000 due to increased operating expenses and interest costs associated with these strategic integrations.NewswireHealthy Extracts Q2 2026 Net Revenue Up 113% to Record $2.1 Million, Driving Adj. EBITDA of $290,000 or $0.02 per ShareHealthy Extracts reported Q2 2026 net revenue of $2.1 million, up 113% year-over-year, with adjusted EBITDA of $290,000 or $0.02 per share. The company also announced a strong growth outlook, citing the acquisition of Sommer Ray's Imaraïs Beauty and major B2B wins.MorningstarHealthy Extracts Q2 2026 Net Revenue Up 113% to Record $2.1 Million, Driving Adj. EBITDA of $290,000 or $0.02 per ShareHealthy Extracts reported Q2 2026 net revenue up 113% to $2.1 million, with adjusted EBITDA of $290,000 or $0.02 per share. The company expects annualized net revenue of over $20 million by year-end, up 3x from last year.Stock TitanHealthy Extracts Expects Record H1 Revenue Above $3.6MHealthy Extracts Inc. expects to report record Q2 2026 net revenue exceeding $2.0 million and H1 2026 net revenue exceeding $3.6 million, representing growth of over 129% and 93% respectively compared to the prior year periods. The growth was driven primarily by the merger with Gummy USA in October 2025 and the acquisition of Imaraïs Beauty in May 2026, which expanded the company's product lines, distribution channels, and B2B customer base. The company projects annualized net revenue of more than $20 million by year end, up more than 3x over last year, supported by its precision dose manufacturing capabilities and existing sales pipeline.FinancialContent Business PageHealthy Extracts Sees First Half 2026 Net Revenue Up More Than 93% to Record $3.6 Million+Healthy Extracts Inc. expects record Q2 2026 net revenue exceeding $2.0 million, representing a 129% increase year-over-year, with first half revenues reaching over $3.6 million, up more than 93% compared to the same period in 2025. The company attributes this growth to the synergistic merger with Gummy USA completed in October 2025 and the acquisition of Imaraïs Beauty in May 2026, both of which expanded its product lines and distribution channels. Management stated the company is on track to potentially achieve annualized net revenue exceeding $20 million by year end, more than three times last year's figures, driven by new B2B customer wins and expanded retail distribution including partnerships with major U.S. retailers.MorningstarHealthy Extracts' Gummy USA Secures Major U.S. Manufacturing Partnership with Imaraïs BeautyHealthy Extracts Inc.'s wholly owned subsidiary Gummy USA has entered a U.S. manufacturing partnership with Imaraïs Beauty, a plant-based ingestible beauty and wellness brand co-founded by Sommer Ray and Aaron Hefter. The partnership launched with an initial order of nearly four million gummies across five SKUs, planned for distribution to over 4,800 store locations nationwide with prominent isle end-cap placements at a leading national retailer. Both companies have characterized this as the beginning of a transformative partnership that will accelerate manufacturing output and expand their presence in the $725 billion global health and beauty market.NasdaqHealthy Extracts' Gummy USA Secures 6 Million Gummy Follow-On Order from Woman's Health Nutraceutical LeaderHealthy Extracts Inc.'s subsidiary Gummy USA has received a $6 million follow-on order for proprietary women's health gummy supplements from a direct-to-consumer nutraceutical leader. The order, scheduled to ship within four weeks, was awarded after competitive evaluation based on Gummy USA's superior formulation technology and ability to handle challenging ingredients. The company states this keeps it on track for another year of record revenue growth and profitability, further validating its advanced manufacturing capabilities.YahooHealthy Extracts' Gummy USA Secures 6 Million Gummy Follow-On Order from Woman's Health Nutraceutical LeaderHealthy Extracts Inc.'s subsidiary Gummy USA has secured a $6 million follow-on order for proprietary women's health gummy formulations from a direct-to-consumer nutraceutical company, with shipment scheduled within four weeks. The follow-on order validates Gummy USA's formulation and manufacturing technology, which the company says sets it apart from competitors through superior gummy texture and flavor even with challenging ingredients. The company states the order keeps it on track for another year of record revenue growth and profitability.ArcstonefinancialpulseTransforming Nutraceutical Innovation Through Science, IP, and Scalable ManufacturingHealthy Extracts Inc. (HYEX) operates a vertically integrated nutraceutical platform, controlling the full product lifecycle from R&D through manufacturing and distribution across the supplement and alternative drug delivery markets. The company has built three product pillars through strategic acquisitions: Bergamet NA (heart health, acquired 2019), Ultimate Brain Nutrients (brain health, acquired 2021), and Gummy USA (gummy supplements, merged July 2025), with the latter adding FDA-registered, GMP-certified manufacturing capacity. The company is targeting an uplisting to a major exchange and projects revenue growth beyond $20M+, positioning itself within a global nutraceutical market projected to reach $987B by 2032.